Baidu, Inc. (BIDU) Accused of Misleading Shareholders   In 2015, Baidu, in its filings with the Securities and Exchange Commission (“SEC”), reported, “In November, we obtained a controlling interest in

Vaxart, Inc. (VXRT) Offers Spring-Loaded Stock Options to Insiders In early 2020, Vaxart’s shares only traded around $0.35 when the Company began developing a COVID-19 vaccine. As time progressed, the

OneSpan Inc. (OSPN) Shocks Investors with Reporting Errors OneSpan Inc. made false and misleading statements regarding the Company’s internal policies and downplayed the likely negative impact on its profits.  On

STAAR Surgical Company (STAA) Accused of Misleading Shareholders   STAAR Surgical reported positive financial results for its fourth quarter and fiscal year ended January 3, 2020.  STAAR Surgical reiterated its positive

Qutuotiao Inc. (QTT) Accused of Misleading Shareholders  Qutuotiao held its IPO on September 14, 2018, offering 13.8 million shares at $7.00 per share for gross proceeds of approximately $85.8 million. 

Robbins LLP Is Investigating the Officers and Directors of Poseida Therapeutics, Inc.  (PSTX) on Behalf of Shareholders Poseida conducted its IPO on July 10, 2020, issuing 14 million shares for

Genius Brands International Inc. (GNUS) Accused of Engaging in Pump-and-Dump Scheme According to the complaint, Genius engaged in a marketing campaign to mislead shareholders and artificially inflate stock prices.  Beginning

Robbins LLP Is Investigating the Officers and Directors of Progenity, Inc. (PROG) on Behalf of Shareholders Progenity conducted its IPO on June 6, 2020, selling approximately 6.7 million shares for

Intel Corporation (INTC) Shocks Investors by Revealing a Yearlong Production Delay for New Product Line Intel and certain of its officers failed to communicate important delays in the expected release